More than a decade ago, Ken Mandl was on a call with a pharmaceutical company and the leader of a social network for people with diabetes. The drug maker was hoping to use the platform to encourage its members to get a certain lab test.
The test could determine a patient’s need for a helpful drug. But in that moment, said Mandl, director of the computational health informatics program at Boston Children’s Hospital, “I could see this focus on a biomarker as a way to increase sales…
Article Source
https://www.statnews.com/2025/03/03/health-ai-clinical-decisions-biomarkup-profits-over-patient-care/
